Literature DB >> 7936282

Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: experiences with 111 patients.

C Klötzsch1, G Janssen, P Berlit.   

Abstract

Patent foramen ovale (PFO) is increasingly recognized in association with cryptogenic stroke. Using transesophageal echocardiography (TEE) and transcranial Doppler sonography with ultrasonic contrast medium (contrast-TCD), we evaluated the frequency of a PFO as the fundamental condition of paradoxical embolism in 111 patients after cerebral ischemia. There was a right-left shunt in 50 patients (45%) with TEE. In 31 of 40 patients with stroke of unknown etiology, a PFO was the only detectable finding associated with cerebral ischemia. Using TEE as the "gold standard," the sensitivity of contrast-TCD was 91.3%, specificity 93.8%, and the overall accuracy 92.8%. Contrast-TCD failed to detect a right-left shunt in four patients, but there were four other patients with negative TEE and positive contrast-TCD. We conclude that contrast-TCD is a highly sensitive method for detecting a right-left shunt. Its advantages are low cost, its ability to detect single contrast-medium embolism, and control of the Valsalva maneuver by observing the decrease of cerebral blood flow. Evidence of PFO in cryptogenic stroke should prompt a search for a subclinical venous thrombosis as the embolic source.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936282     DOI: 10.1212/wnl.44.9.1603

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Transcranial Doppler ultrasonography in the detection of venous to arterial shunting in acute stroke and transient ischaemic attacks.

Authors:  M Yeung; K A Khan; A Shuaib
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

2.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1].

Authors:  P Ringleb; P D Schellinger; W Hacke
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

Review 3.  Review of transcranial Doppler ultrasound to detect microemboli during orthopedic surgery.

Authors:  B S Silbert; L A Evered; D A Scott; S Rahardja; R P Gerraty; P F Choong
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-22       Impact factor: 3.825

Review 4.  Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.

Authors:  D J H McCabe; R D Rakhit
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

5.  Patent foramen ovale and stroke: prognosis and treatment in young adults.

Authors:  Steven C Cramer
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

Review 6.  Patent foramen ovale and stroke.

Authors:  Shunichi Homma; Marco R Di Tullio
Journal:  J Cardiol       Date:  2010-06-29       Impact factor: 3.159

7.  [Detection of patent foramen ovale. Transesophageal echocardiography and transcranial Doppler sonography with ultrasound contrast media are "supplementary, not competing, diagnostic methods"].

Authors:  J G Heckmann; W Niedermeier; M Brandt-Pohlmann; M J Hilz; M Hecht; B Neundörfer
Journal:  Med Klin (Munich)       Date:  1999-07-15

8.  Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?

Authors:  Alawi A Alsheikh-Ali; David E Thaler; David M Kent
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

9.  [Detection of cardial and extracardial right-to-left shunts in young stroke patients].

Authors:  V Sirkis; B Fraiture; S Gass; G Layer; R Zahn; J Senges; A Grau
Journal:  Nervenarzt       Date:  2008-02       Impact factor: 1.214

10.  Patent foramen ovale in severe obstructive sleep apnea: clinical features and effects of closure.

Authors:  Zarrin F Shaikh; Jay Jaye; Neil Ward; Atul Malhotra; Manuel de Villa; Michael I Polkey; Michael J Mullen; Mary J Morrell
Journal:  Chest       Date:  2013-01       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.